A case of postoperative pancreatitis in patients with renal cell carcinoma with an inferior vena cava tumor thrombus treated by presurgical lenvatinib plus pembrolizumab

被引:0
作者
Masahiro Kurokawa
Daiki Ikarashi
Renpei Kato
Mitsugu Kanehira
Takashi Fukagai
Wataru Obara
机构
[1] Iwate Medical University School of Medicine,Department of Urology
[2] Showa University School of Medicine,Department of Urology
来源
International Cancer Conference Journal | 2024年 / 13卷
关键词
Pembrolizumab; Lenvatinib; Renal cell carcinoma; Inferior vena cava thrombus; Pancreatitis;
D O I
暂无
中图分类号
学科分类号
摘要
Pancreatic injury is a rare, but noted complication of nephrectomy. We report a case involving a 56-year-old man who presented with cT3bN0M0 left locally advanced renal cell carcinoma with an inferior vena cava thrombus. Nephrectomy with thrombectomy was performed given the remarkable shrinkage of the primary tumor and thrombus following lenvatinib plus pembrolizumab administration. The patient developed postoperative pancreatitis associated with unrecognized minor pancreatic injury, which was treated conservatively. To our knowledge, this has been the first case that underwent nephrectomy for RCC with an IVC thrombus after presurgical lenvatinib plus pembrolizumab and received conservative treatment for postoperative pancreatitis.
引用
收藏
页码:158 / 161
页数:3
相关论文
共 47 条
[1]  
Klatte T(2007)Prognostic factors for renal cell carcinoma with tumor thrombus extension J Urol 178 1189-1195
[2]  
Pantuck AJ(2022)Jikei-Kyoto-Osaka-Nagasaki-Ganken Group (J-KONG Group): Intra- and post-operative management of pancreatic injury during laparoscopic nephrectomy Int J Urol 29 905-907
[3]  
Riggs SB(2022)Lenvatinib plus pembrolizumab combination therapy for adult patients with advanced renal cell carcinoma Expert Rev Anticancer Ther 22 1049-1059
[4]  
Miki J(2022)Immune checkpoint inhibitor combination therapy for renal cell carcinomas with concomitant inferior vena cava thrombi In Vivo 9 101800-129
[5]  
Yamasaki T(2021)Pathological complete response of renal cell carcinoma with vena cava tumor thrombus to neoadjuvant TKI/IO combination therapy Urol Case Rep 3 124-248
[6]  
Komai Y(2023)Pathological complete response to preoperative nivolumab plus cabozantinib for renal cell carcinoma with inferior vena cava thrombus: a case report Cancer Diagn Progn 22 244-1769
[7]  
Ged Y(2020)Management of pancreatic injuries following nephrectomy Isr Med Assoc J 47 1763-385
[8]  
Lee CH(2015)Possible impact of continuous drainage after minimally invasive partial nephrectomy Int Urol Nephrol 31 379-S20
[9]  
Yoshida K(2013)Surgical outcomes and complications associated with presurgical tyrosine kinase inhibition for advanced renal cell carcinoma (RCC) Urol Oncol 6 S8-1833
[10]  
Hata K(2017)Evaluation of rare but severe immune related adverse effects in PD-1 inhibitors in non-small cell lung cancer: a meta-analysis Transl Lung Cancer Res 375 1823-1550